This controlled trial investigates the efficacy of Groups 4 Health to improve the mental health of people of higher weight through psychotherapy and behaviour change, decreasing feelings of loneliness and weight stigma through social networks.

The Aligned Study is an investigator-initiated, randomized controlled trial of pharmacogenomic-guided therapy versus standard care for people with depression who require initiation or change in antidepressant therapy.

The primary objective of this project is to investigate psychological, cognitive and physiological changes associated with a single session of psychedelic drug exposure with psilocybin or 3,4-methylenedioxymethamphetamine (MDMA) in a group setting.

The project has been designed for the collection of outcome and safety data on the use of novel interventional pharmacotherapy approaches. The AIPPAP Research Registry is designed to capture real-world clinical data on the use of ketamine, MDMA, and psilocybin.

This project aims to analyze the circulating miRNA pre-operation of the TKA and knee tissue mRNA post primary TKA.

Bacterial resistance to antibiotics is one of the most serious challenges to global public health, as drug resistance has been found for all classes of antibiotics used in clinical practice.